• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Does A Failed NIPS Screen Indicate Increased Risk for Chromosomal Abnormalities?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Bellai-dussault et al. (AJOG, 2023) assessed the association between a failed cell-free DNA (cfDNA) test and common aneuploidies

METHODS:

  • Population-based retrospective cohort study
    • Data derived from the Better Outcomes Registry and Network (BORN) province-wide database in Ontario, Canada
  • Population
    • All singleton pregnancies with cfDNA screening record
    • Delivered from September 2016 to March 2019
  • Exposures
    • Failed cfDNA screen on first attempt
    • Successful cfDNA screen with low-risk result
  • Study design
    • Modified Poisson regressions were used to determine relative risk (RR)
    • Adjustments: Funding status (publicly funded versus self-paid) | Gestational age at screening | Method of conception | Maternal age
  • Primary outcome
    • Trisomies 21, 18, 13 and sex chromosome aneuploidies

RESULTS:

  • 35,146 pregnancies underwent cfDNA screening
  • Overall cfDNA screening failure rates
    • First attempt: 4.8%
    • Multiple attempts: 2.2%
  • Abnormal cytogenetic results in patients with failed cfDNA screening: 19.4%
  • Pregnancies with a failed cfDNA screen on first attempt had a higher risk for trisomies 21, 18, 13 vs successful, low-risk cfDNA screen results
    • RR 130.3 (95% CI, 64.7 to 262.6)
    • Risk difference: 5.4% (95% CI, 2.6 to 8.3)
  • Risk for sex chromosome aneuploidies was not significantly greater in pregnancies with a failed result vs low-risk result
    • RR 2.7 (95% CI, 0.9 to 7.9)
    • Risk difference 1.2% (95% CI, –0.9 to 3.2)

CONCLUSION:

  • Failed NIPS screens are fairly common at 5%
  • Pregnancies with a failed first attempt are at a higher risk of trisomies 21, 18, and 13, but not sex chromosome aneuploidies
  • The authors state

Further, a failed cfDNA screen is associated with an increased risk of chromosomal abnormalities, regardless of the number of attempts

This study provides valuable information for clinicians as well as policy makers who consider performance of cfDNA screening in prenatal screening programs

Learn More – Primary Sources:

Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

NIPS Failure:  How Does BMI Relate to Fetal Fraction and Gestational Age?
SMART Study: NIPS Aneuploidy Screening Performance Among Both Low and High-Risk Pregnancies
Practical info on evidence based medicine for your women's healthcare practice
cfDNA vs. Routine Screening – How Do They Compare?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site